1
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran; Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
2
Department of Biology, Science and Research branch, Islamic Azad University, Tehran, Iran
3
Department of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
4
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
Keshmiri Neghab,H , Azadeh,S S , Soheilifar,M H and Dashtestani,F . (2020). Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19. Avicenna Journal of Medical Biotechnology, 12(4), 255-256.
MLA
Keshmiri Neghab,H , , Azadeh,S S , , Soheilifar,M H , and Dashtestani,F . "Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19", Avicenna Journal of Medical Biotechnology, 12, 4, 2020, 255-256.
HARVARD
Keshmiri Neghab H, Azadeh S S, Soheilifar M H, Dashtestani F. (2020). 'Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19', Avicenna Journal of Medical Biotechnology, 12(4), pp. 255-256.
CHICAGO
H Keshmiri Neghab, S S Azadeh, M H Soheilifar and F Dashtestani, "Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19," Avicenna Journal of Medical Biotechnology, 12 4 (2020): 255-256,
VANCOUVER
Keshmiri Neghab H, Azadeh S S, Soheilifar M H, Dashtestani F. Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19. AJMB. 2020;12(4):255-256.
